Biomarkers for stroke detection
Pro Research Analysisby 
Searched over 200M research papers
Blood Biomarkers for Stroke Detection: Key Types and Their Roles
Blood biomarkers are increasingly studied for their potential to improve the early detection, diagnosis, and management of stroke. These markers can help distinguish between stroke types, predict outcomes, and guide treatment decisions, offering advantages such as rapid results and lower costs compared to imaging. However, no single biomarker has yet achieved the sensitivity and specificity required for routine clinical use, and a multi-marker approach is often recommended for better accuracy Anwar2024Liang2025Kamtchum-Tatuene2019+2 MORE.
Lipid and Metabolic Biomarkers in Stroke Risk Prediction
Non-traditional lipid markers, such as triglycerides and non-high-density lipoprotein cholesterol, have shown greater predictive value for stroke risk than traditional low-density lipoprotein cholesterol. Additionally, metabolomic studies have identified novel markers like tetradecanedioate and hexadecanedioate, which are associated with specific stroke subtypes, such as cardioembolic stroke .
Inflammatory and Hemodynamic Markers for Stroke Diagnosis
Inflammatory markers, particularly interleukin-6 (IL-6), are strongly associated with increased stroke risk. Hemodynamic markers, including midregional proatrial natriuretic peptide (MRproANP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), have demonstrated potential in distinguishing between different stroke subtypes and predicting disease progression Anwar2024Liang2025Bustamante2021+2 MORE.
Neuronal and Axonal Injury Markers
Markers of neuronal and axonal injury, such as glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), and neurodegenerative markers like total-tau and neurofilament light chain, are linked to both stroke diagnosis and prognosis. GFAP, in particular, is useful in differentiating ischemic from hemorrhagic stroke, especially when combined with other markers Anwar2024Bustamante2021Wang2024.
MicroRNAs and Circular RNAs as Novel Biomarkers
Specific microRNAs (miR-125a-5p, miR-125b-5p, miR-143-3p) are upregulated in acute ischemic stroke, and circulating circular RNAs (circRNAs) have shown promise for both diagnosis and outcome prediction. A combination of three circRNAs achieved high specificity and sensitivity in acute ischemic stroke diagnosis and was also effective in predicting patient outcomes Anwar2024Liang2025Zuo2019.
Proteomic and Multi-Marker Panels
Proteomic approaches have identified new blood proteins, such as complement component 3 (C3), intercellular adhesion molecule 2 (ICAM-2), and plasminogen-like A (PLGLA), which can help differentiate between ischemic and hemorrhagic strokes. Multi-marker panels, including combinations of RBP-4, NT-proBNP, and GFAP, have shown moderate accuracy in distinguishing stroke types, especially when integrated with clinical variables Bustamante2021Bustamante2017Marto2023.
Point-of-Care Testing and Technological Advances
Recent advances in point-of-care testing (POCT), such as surface-enhanced Raman scattering-based lateral flow immunoassays (SERS-based LFIA), allow for rapid and sensitive detection of multiple stroke biomarkers (e.g., MMP-9, NSE, NT-proBNP) simultaneously. These technologies have demonstrated high accuracy and consistency with traditional laboratory methods, making them promising for clinical application .
Challenges and Future Directions in Stroke Biomarker Research
Despite the identification of many promising biomarkers, challenges remain, including variability in stroke etiology, the complexity of the ischemic cascade, and technical issues with biomarker measurement. No single biomarker currently meets all the requirements for routine clinical use, and further large-scale validation studies are needed. Standardization of laboratory and clinical procedures is essential to optimize biomarker performance. A comprehensive, multi-marker approach, combined with clinical data, is likely to provide the most reliable tools for stroke detection and management in the future Anwar2024Liang2025Bustamante2017+3 MORE.
Conclusion
Blood biomarkers hold significant promise for improving stroke detection, differentiation, and prognosis. While individual markers such as NT-proBNP, GFAP, and specific microRNAs and circRNAs show potential, combining multiple biomarkers with clinical variables offers the best chance for accurate and rapid stroke diagnosis. Continued research and technological innovation are needed to bring these advances into routine clinical practice.
Sources and full results
Most relevant research papers on this topic